Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Interaction between digoxin and dronedarone in the PALLAS trial
Pallas Investigators
Clinical Departments
Internal Medicine
Goethe University Frankfurt
Icahn School of Medicine at Mount Sinai
St. George's University of London
McMaster University
Sanofi-Aventis
Research output
:
Contribution to journal
›
Article
›
peer-review
58
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Interaction between digoxin and dronedarone in the PALLAS trial'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Digoxin
100%
Pallas
100%
Dronedarone
100%
Placebo
46%
Cardiovascular Mortality
30%
Adverse Effects
15%
Confidence Interval
15%
Adjusted Hazard Ratio
15%
Heart Failure
15%
Persistent Atrial Fibrillation
15%
Arrhythmic Death
15%
P-glycoprotein (P-gp)
7%
Subgroup Analysis
7%
Adverse Outcomes
7%
Serum Concentration
7%
Heart Failure Events
7%
Serum Digoxin Concentration
7%
Pharmacology, Toxicology and Pharmaceutical Science
Digoxin
100%
Dronedarone
100%
Placebo
46%
Congestive Heart Failure
23%
Adverse Event
15%
Permanent Atrial Fibrillation
15%
Adverse Outcome
7%
P-Glycoprotein
7%